Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
(NASDAQ: DNLI) Delayed: 22.28 -0.52 (2.28%)
Previous Close $22.80    52 Week High
Open $22.32    52 Week Low
Day High $22.48    P/E N/A 
Day Low $22.15    EPS
Volume 799,634